Silver Book Fact

Without screening and adjuvant therapy, the death rate for breast cancer would have increased by about 30 percent between 1975 and 2000.

Berry, D, K Cronin, S Plevritis, D Fryback, L Clarke, et al. Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer. NEJM. 2005; 353(17): 84-92. http://www.nejm.org/doi/full/10.1056/NEJMoa050518

Reference

Title
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Publication
NEJM
Publication Date
2005
Authors
Berry, D, K Cronin, S Plevritis, D Fryback, L Clarke, et al.
Volume & Issue
Volume 353, Issue 17
Pages
84-92
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, a medicine to fight breast cancer is currently in the pipeline. It targets the Bcl-2 protein, which appears to contribute…  
  • If the use of recommended colorectal screening increased to 70.5 percent, 1,000 additional lives could be saved each year.  
  • Gains in healthy years of life and social value from cancer R&D
     
  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in development is designed to induce a powerful immune response to melanoma.  
  • Studies have shown that annual mammograms reduce breast cancer related mortality in women by 20-40%.